EP3600419
TREATMENT OF CANCER WITH A SEMAPHORIN-4D ANTIBODY IN COMBINATION WITH AN EPIGENETIC MODULATING AGENT
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
14.3.2018EP published:
9.8.2023EP application number:
18771465.4
EPO information:
European Patent Register
Max expiry date:
13.3.2038
Title in English:
TREATMENT OF CANCER WITH A SEMAPHORIN-4D ANTIBODY IN COMBINATION WITH AN EPIGENETIC MODULATING AGENTLanguage of the patent:
English
Timeline
Today
14.3.2018EP application
9.8.2023EP Publication
Owner
Name:
Vaccinex, Inc.Address:
1895 Mt. Hope Avenue, Rochester, NY 14620, US
Inventor
Name:
EVANS, ElizabethAddress:
Bloomfield, New York 14469, US
Name:
SMITH, Ernest S.Address:
West Henrietta, New York 14586, US
Name:
ZAUDERER, MauriceAddress:
Pittsford, New York 14534, US
Priority
Number:
201762473731 PDate:
20.3.2017Country:
US
Classification
Categories:
A61K 39/395, A61P 35/00, C07K 16/28, A61K 31/4406, A61K 31/7068, A61K 45/06